Vivek Verma

6PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 16, 2026
Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer.

Baldev Singh, Pankaj Gaur, Pritha Bose

|Jan 12, 2026
PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming.

Wael Traboulsi, Pankaj Gaur, Subhadip Kundu

|Jul 03, 2023
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.

Kristin G Anderson, David A Braun, Aitziber Buqué

|Nov 22, 2022
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis.

Fabia de Oliveira Andrade, Vivek Verma, Leena Hilakivi-Clarke

|Mar 15, 2022
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status.

Rahul Nandre, Vivek Verma, Pankaj Gaur

|Nov 24, 2020
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.

Vivek Verma, Nazli Jafarzadeh, Shannon Boi

Pageof 1

Frequent Collaborators

4 joint publications

Seema Gupta

3 joint publications

Samir N Khleif

3 joint publications

Pankaj Gaur

2 joint publications

Nour Shobaki